Clinical predictors of survival in men with castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Clinical predictors of survival in men with castration-resistant prostate cancer

Published:2013-05-29 Issue:16 Volume:119 Page:2990-2998
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nakabayashi Mari¹,Hayes Julia¹,Taplin Mary-Ellen¹,Lefebvre Patrick²,Lafeuille Marie-Helene²,Pomerantz Mark¹,Sweeney Christopher¹,Duh Mei Sheng²,Kantoff Philip W.¹

Affiliation:

1. Lank Center for Genitourinary Oncology; Dana-Farber Cancer Institute and Harvard Medical School; Boston Massachusetts

2. Analysis Group, LLC; Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28102/fullpdf

Reference16 articles.

1. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response;Ryan;Clin Cancer Res,2011

2. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

5. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration;Smaletz;J Clin Oncol,2002

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgendeprivation als Initial- und Basistherapie beim Prostatakarzinom;Die Urologie;2024-08-29

2. Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice;Frontiers in Oncology;2024-01-23

3. Establishment and assessment of a nomogram for predicting prognosis in bone-metastatic prostate cancer;Medicine;2023-11-03

4. Treatment Patterns Among Patients With Advanced Prostate Cancer in Brazil: An Analysis of a Private Healthcare System Database;World Journal of Oncology;2022-12

5. ¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración?;Actas Urológicas Españolas;2022-11